Cargando…

Remission of type 2 diabetes in a hypogonadal man under long-term testosterone therapy

In daily practice, clinicians are often confronted with obese type 2 diabetes mellitus (T2DM) patients for whom the treatment plan fails and who show an inadequate glycemic control and/or no sustainable weight loss. Untreated hypogonadism can be the reason for such treatment failure. This case descr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haider, Ahmad, Haider, Karim S, Saad, Farid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2017
Materias:	Novel Treatment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592703/ https://www.ncbi.nlm.nih.gov/pubmed/28924480 http://dx.doi.org/10.1530/EDM-17-0084

Ejemplares similares

Remission of type 2 diabetes and pleiotropic effects of long-term testosterone treatment for “late-onset” hypogonadism: A case report
por: Haider, Ahmad, et al.
Publicado: (2019)

Switch to restoration therapy in a testosterone treated central hypogonadism with erythrocytosis
por: Cangiano, B, et al.
Publicado: (2017)

Dose-dependent response to long-term clomiphene citrate in male functional hypogonadotropic hypogonadism
por: Lin, Beryl, et al.
Publicado: (2023)

SUN-083 Hypertension and Hemodynamic Parameters in Men with Hypogonadism Improve Under Long-Term Treatment with Testosterone Undecanoate Injections (TU) Compared to Untreated Hypogonadal Control Patients
por: Saad, Farid, et al.
Publicado: (2019)

Congenital hypogonadotrophic hypogonadism, induction of minipuberty, and future fertility
por: Stuckey, Bronwyn G A, et al.
Publicado: (2023)

Remission of type 2 diabetes following long‐term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11‐year data from a real‐world registry study
por: Haider, Karim Sultan, et al.
Publicado: (2020)

Successful long-term use of pioglitazone in Berardinelli–Seip lipodystrophy-associated diabetes
por: Chaves, Carolina, et al.
Publicado: (2021)

Effects of Long-Term Testosterone Therapy on Patients with “Diabesity”: Results of Observational Studies of Pooled Analyses in Obese Hypogonadal Men with Type 2 Diabetes
por: Haider, Ahmad, et al.
Publicado: (2014)

SUN-226 Improvements In Quality Of Life In Men With Hypogonadism Under Long-term Testosterone Therapy (TTh) With Testosterone Undecanoate Injections (TU): Experience From 6,500 Patient-years Ina Registry Study Ina Urological Setting
por: Haider, Karim, et al.
Publicado: (2019)

Effective long-term temozolomide rechallenge in a macroprolactinoma
por: Zampetti, Benedetta, et al.
Publicado: (2018)

OR21-2 Lipid Profiles Improve in Men With Hypogonadism and Pre-existing Cardiovascular Disease Under Long-term Testosterone Therapy (TTh) With Testosterone Undecanoate Injections (TU): 10-year Data From a Controlled Registry Study in a Urological Setting
por: Haider, Ahmad, et al.
Publicado: (2019)

Long-term low-dose ketoconazole treatment in bilateral macronodular adrenal hyperplasia
por: Comte-Perret, Sophie, et al.
Publicado: (2014)

MON-091 Profound and Sustained Weight Loss in Men With Hypogonadism and Obesity Receiving Long-Term Testosterone Therapy (TTh) with Testosterone Undecanoate Injections (TU): 10-Year Data from a Registry Study in a Urological Setting
por: Haider, Karim, et al.
Publicado: (2019)

Management of adrenocortical insufficiency with continuous subcutaneous hydrocortisone infusion: long-term experience in three patients
por: Khanna, A, et al.
Publicado: (2015)

SAT-533 Men with Hypogonadism and Osteoporosis Benefit from Long-Term Testosterone Therapy (TTh) with Testosterone Undecanoate Injections (TU) Regardless of Co-Medication with Bisphosphonates: 10-Year Data from a Controlled Registry Study in a Urological Setting
por: Haider, Ahmad, et al.
Publicado: (2019)

SUN-055 Reduction of Mortality and Major Adverse Cardiovascular Events (MACE) in Men with Hypogonadism Treated with Long-Term Testosterone Therapy (TTh) with Testosterone Undecanoate Injections (TU): 10-Year Data from a Registry Study in a Urological Setting
por: Saad, Farid, et al.
Publicado: (2019)

The use of SGLT2 inhibitors in achieving glycaemic control in maturity-onset diabetes of the young type 3
por: Sriravindrarajah, Arunan, et al.
Publicado: (2021)

Utilising a milk-based meal replacement programme in a bariatric patient with poorly controlled type 2 diabetes mellitus
por: Maher, Michelle, et al.
Publicado: (2019)

Insulin degludec overdose in an adolescent with type 1 diabetes: proactive management including monitoring using the Freestyle Libre flash glucose monitoring system
por: Thompson, Harmony, et al.
Publicado: (2018)

Long-Term Testosterone Therapy Improves Cardiometabolic Function and Reduces Risk of Cardiovascular Disease in Men with Hypogonadism: A Real-Life Observational Registry Study Setting Comparing Treated and Untreated (Control) Groups
por: Traish, Abdulmaged M., et al.
Publicado: (2017)

Effect of Astragalus membranaceus extract on diabetic nephropathy
por: Kim, Jiman, et al.
Publicado: (2014)

Use of plasma rich in growth factors for symptoms of diabetic neuropathy
por: Roman, S J, et al.
Publicado: (2023)

Pasireotide in an insulin-requiring diabetic acromegalic patient without worsening of hyperglycemia
por: Gordon, Murray B, et al.
Publicado: (2017)

Use of acetazolamide in lithium-induced nephrogenic diabetes insipidus: a case report
por: Macau, Ricardo A, et al.
Publicado: (2018)

Plasma exchange in the treatment of thyroid storm secondary to type II amiodarone-induced thyrotoxicosis
por: Zhu, Ling, et al.
Publicado: (2016)

A case of type B insulin resistance syndrome treated with low-dose glucocorticoids
por: Kotani, Masato, et al.
Publicado: (2019)

Mesenchymal stem cells derivatives as a novel and potential therapeutic approach to treat diabetic foot ulcers
por: Becerra-Bayona, Silvia M, et al.
Publicado: (2020)

Catecholamine-secreting carotid body paraganglioma: successful preoperative control of hypertension and clinical symptoms using high-dose long-acting octreotide
por: Elshafie, Omayma, et al.
Publicado: (2014)

SUN-LB114 Remission of Type 2 Diabetes (DMT2) in Hypogonadal Men Under Long-Term Testosterone Therapy
por: Mskhalaya, George, et al.
Publicado: (2020)

Arginine-vasopressin infusion in a child with cranial diabetes insipidus during hyperhydration therapy with chemotherapy: a therapeutic challenge
por: Devaraja, Janani, et al.
Publicado: (2021)

Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study
por: Traish, A M, et al.
Publicado: (2014)

Cardiovascular Disease, Hypogonadism and Erectile Dysfunction: Early Detection, Prevention and the Positive Effects of Long-Term Testosterone Treatment: Prospective Observational, Real-Life Data
por: Alwani, Mustafa, et al.
Publicado: (2021)

Hypogonadal men with moderate-to-severe lower urinary tract symptoms have a more severe cardiometabolic risk profile and benefit more from testosterone therapy than men with mild lower urinary tract symptoms
por: Saad, Farid, et al.
Publicado: (2018)

New Methods for Direct Delivery of Chemotherapy for Treating Brain Tumors
por: Sawyer, Andrew J., et al.
Publicado: (2007)

MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian cancer
por: Silasi, Dan-Arin, et al.
Publicado: (2007)

A 15-year-old adolescent with a rare pituitary lesion
por: Manousaki, Despoina, et al.
Publicado: (2014)

The use of cinacalcet in pregnancy to treat a complex case of parathyroid carcinoma
por: Nadarasa, K, et al.
Publicado: (2014)

Pasireotide therapy in a rare and unusual case of plurihormonal pituitary macroadenoma
por: Rajendran, Rajesh, et al.
Publicado: (2013)

Successful treatment of neonatal severe hyperparathyroidism with cinacalcet in two patients
por: Fisher, Marisa M, et al.
Publicado: (2015)

Fluconazole and acetazolamide in the treatment of ectopic Cushing's syndrome with severe metabolic alkalosis
por: Schwetz, Verena, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3d2m98oll7sscloajk8fib4dog